Lion TCR

Singapore, Singapore

Lion TCR is a clinical-stage biotechnology company.

$41.6M raised

Jun 2023

Series B

Biotechnology Health Care Health Diagnostics Therapeutics

Top Investors

Guangzhou Industrial Investment Group Guangzhou Guoju Venture Capital Westlake Venture Partners CSPC NARD Capital Yashang Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lion TCR

How much funding has Lion TCR raised?

Lion TCR has raised $41.6M in total funding. The most recent round was Series B. The last funding was announced in June 2023.

Who are Lion TCR's investors?

Lion TCR's investors include Guangzhou Industrial Investment Group, Guangzhou Guoju Venture Capital, Westlake Venture Partners, CSPC NARD Capital, Yashang Capital.

Where is Lion TCR headquartered?

Lion TCR is headquartered in Singapore, Singapore.

What does Lion TCR do?

Lion TCR is a clinical-stage biotechnology company.

What stage is Lion TCR at?

Lion TCR is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2023.

MLA

"Lion TCR — Funding & Investors." VCBacked, June 27, 2023, https://www.vcbacked.co/company/lion-tcr. Accessed July 2, 2026.

APA

VCBacked. (2023). Lion TCR — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lion-tcr

Wikipedia (cite web)

{{cite web |title=Lion TCR — Funding & Investors |url=https://www.vcbacked.co/company/lion-tcr |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K